Goolden A W, Goldman J M, Kam K C, Dunn P A, Baughan A S, McCarthy D M, Worsley A M, Gordon-Smith E C, Samson D, Catovsky D, Galton D A
Br J Radiol. 1983 Apr;56(664):245-50. doi: 10.1259/0007-1285-56-664-245.
Thirty patients in various stages of acute leukaemia or chronic granulocytic leukaemia (CGL) were treated with cytotoxic drugs followed by whole body irradiation (TBI) administered in 200 cGy fractions twice daily to a total of 1000 or 1200 cGy. The immediate toxicity of fractionated TBI administered in this way was negligible and patients required only minor premedication and little treatment subsequently for complications attributable to TBI. Fourteen (47%) patients have died, ten of the 12 transplanted with active disease, and four of the 18 subjected to transplantation in remission of acute leukaemia or in chronic phase of CGL. Though the duration of follow-up is still short, no patient in the latter group (follow-up of survivors ranging from six to 146 weeks) has yet relapsed with any evidence of recurrent leukaemia. We conclude that this method of fractionating TBI reduced toxicity for the patient without necessarily reducing its antileukaemic effect.
30例处于急性白血病或慢性粒细胞白血病(CGL)各阶段的患者接受了细胞毒性药物治疗,随后进行全身照射(TBI),每日两次,每次200 cGy,总量为1000或1200 cGy。以这种方式进行的分次TBI的即时毒性可忽略不计,患者仅需少量预处理,且后续因TBI引起的并发症所需治疗也很少。14例(47%)患者已死亡,12例移植时患有活动性疾病的患者中有10例死亡,18例在急性白血病缓解期或CGL慢性期接受移植的患者中有4例死亡。尽管随访时间仍然较短,但后一组患者(幸存者随访时间为6至146周)中尚无患者出现复发性白血病的任何证据。我们得出结论,这种分次TBI的方法降低了对患者的毒性,而不一定降低其抗白血病作用。